Marion Gasperment is the COO of AblaCare, a medtech startup developing a minimally invasive treatment of PolyCystic Ovary Syndrome (PCOS) related infertility, created by the Paris based accelerator MD Start in 2017. Marion is also involved with MD Start, where she manages the deal flow and focuses on the identification and evaluation of the most promising ideas for incubation.
Prior to joining MD Start, Marion was the COO of Cardiologs Technologies, a French medtech start-up leveraging machine learning and expertise in cardiology to provide the most advanced system for arrhythmia screening. As a member of the executive leadership team, she was heavily involved in fundraising, business development, and market access strategy for the company. She also managed regulatory and clinical affairs, and worked closely with key opinion leaders and researchers around the world.
Marion holds a Bachelor in Biomedical Science from Imperial College London, and a Master in Management (major in Entrepreneurship) from HEC Paris."